查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1453906

到 2030 年芽孢桿菌凝固劑市場預測：按產品類型、型態、分銷管道、應用、最終用戶和地區進行的全球分析

Bacillus Coagulans Market Forecasts to 2030 - Global Analysis By Product Type (Animal-Based and Plant-Based), Form (Spore, Liquid and Powder), Distribution Channel, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年凝結芽孢桿菌的全球市場規模為 1.03 億美元，預計在預測期內將以 10.1% 的年複合成長率成長，並在 2030 年達到 2.02 億美元。

凝結芽孢桿菌是一種有益細菌，通常用作益生菌，因為它能夠促進消化器官系統健康和支持免疫功能。它是一種形成孢子、產生乳酸的細菌，可以承受高溫、酸度和膽鹽等惡劣條件，使其具有高度的彈性和有效的營養補充。形成孢子的乳酸菌可透過抑制有害細菌的生長並促進有益細菌的生長，有助於維持腸道菌叢的健康平衡。

擴大益生菌

益生菌因其潛在的健康益處而受到廣泛關注，特別是支持消化器官系統健康和免疫功能。作為一種益生菌，凝結芽孢桿菌正受益於此不斷成長的市場趨勢。此外，醫療保健專業人員和研究人員透過科學研究和臨床試驗積極宣傳包括凝結芽孢桿菌在內的益生菌的益處。這些研究的正面結果有助於增強人們對益生菌作為可行健康解決方案的信任和接受，進一步支持市場擴張。

產品穩定性

凝結芽孢桿菌是一種活菌，對溫度、濕度和氧氣暴露等各種環境因素敏感。然而，凝結芽孢桿菌可能對最佳生長和存活有特定的要求，例如 pH 值、營養可用性以及與其他成分的相容性。在產品的整個保存期限內保持凝結芽孢桿菌的穩定性和活力是很困難的，產品的不穩定性會影響其有效性和消費者信心，從而抑制市場需求。

消費者意識不斷增強

隨著消費者越來越意識到自己的健康和福祉，對支持消化器官系統健康的天然有效解決方案的需求不斷增加。孢子形成乳酸菌因其特性而作為潛在的治療劑而引起人們的關注，從而導致消費者意識和需求的增加。此外，健康和保健出版物、線上資源、社交媒體和口碑推薦都在教育消費者了解凝結芽孢桿菌的益處方面發揮作用。

替代產品的競爭

乳酸桿菌和雙歧桿菌等替代益生菌菌株具有類似的健康益處，並且在市場上已確立地位，形成了競爭格局。此外，益生元、合益素和傳統藥物等非益生菌替代品也正在爭取類似健康狀況和健康目標的市場佔有率。既定競爭對手和替代產品的存在強調了芽孢桿菌凝固劑產品差異化和價值提案的重要性，並影響市場需求。

COVID-19 的影響

全球凝結芽孢桿菌市場受到 COVID-19 大流行的嚴重影響。這場大流行導致人們重新評估健康優先事項，導致對含有凝結芽孢桿菌的機能性食品和益生菌的需求增加。此外，疫情也造成供應鏈中斷，影響了各地區機能性食品的商業性生產。

預計粉末細分市場在預測期內將是最大的

由於其多功能性、便利性和易於融入各種應用，粉末產業預計將佔據最大的市場佔有率。凝結芽孢桿菌粉是益生菌的濃縮型態，常用於營養補充、機能性食品和飼料添加劑。此外，凝結芽孢桿菌粉末補充品為消費者提供了一種將益生菌融入日常生活的便捷方式。該粉末可以混合到食品和飲料、優格中，或撒在食品上，提供一種簡單且可客製化的方法來促進腸道健康和免疫力。

預計非乳製品產業在預測期內年複合成長率最高

由於對無乳製品、純素友善和益生菌產品的需求不斷增加，預計非乳製品市場在預測期內將出現良好成長。由於凝結芽孢桿菌是一種有彈性的孢子形成細菌，因此適合添加到非乳製品食品和食品和飲料中，為消費者提供獲得益生菌相關健康益處的另一種選擇。此外，清潔標籤和天然成分的成長趨勢將進一步推動對非乳製品益生菌選擇的需求，因為凝結芽孢桿菌通常被認為是一種天然且清潔標籤友善的成分。

佔比最大的地區：

在估計期間，北美佔據了最大的市場佔有率。隨著消費者越來越意識到消化器官系統健康的重要性，對含有凝結芽孢桿菌的產品的需求正在增加。這種需求是由忙碌的生活方式、不良的飲食習慣和胃腸道疾病增加等因素所推動的。此外，北美，特別是美國和加拿大的法規環境支持在食品和營養補充中使用凝結芽孢桿菌，進一步推動市場成長。

年複合成長率最高的地區：

由於亞太地區人口眾多且多樣化、可支配收入不斷增加以及健康意識不斷增強，預計亞太地區在預測期內將出現盈利成長。凝結芽孢桿菌具有承受高溫和酸性環境的能力，使其適合發酵過程，使其成為增加泡菜、味噌、Tempeh和泡菜等傳統亞洲食品的營養價值和益生菌含量的流行選擇。此外，胃腸道疾病和消化器官系統健康問題在該地區普遍存在，導致人們越來越認知到腸道健康和益生菌的重要性。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球芽孢桿菌凝固市場：依產品類型

  • 動物起源
  • 植物來源

第6章全球芽孢桿菌凝固市場：型態

  • 孢子
  • 液體
  • 粉末

第7章全球芽孢桿菌凝固市場：依通路

  • 線下零售
  • 網路零售

第8章全球芽孢桿菌凝固市場：依應用分類

  • 糧食
  • 嬰兒營養
  • 非乳製品
  • 益生菌補充品
  • 其他用途

第9章全球芽孢桿菌凝固市場：依最終用戶分類

  • 飲食
  • 化妝品
  • 營養補充食品
  • 藥品
  • 家畜
  • 其他最終用戶

第10章全球芽孢桿菌凝固市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第11章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章 公司簡介

  • Mitsubishi Chemical Foods Corporation
  • Aumgene Bioscience
  • Nebraska Cultures
  • Syngen Biotech
  • Sabinsa Corporation
  • UAS Laboratories
  • Ganeden
  • Microbax
  • Mystical Biotech Pvt. Ltd
  • Sanzyme
  • Synbiotics Limited
  • Lallemand Inc.
  • Bioriginal Food & Science Corp.
  • Unique Biotech Limited
  • Biovation Labs Inc.
Product Code: SMRC25458

According to Stratistics MRC, the Global Bacillus Coagulans Market is accounted for $103 million in 2023 and is expected to reach $202 million by 2030 growing at a CAGR of 10.1% during the forecast period. Bacillus coagulans is a beneficial bacterium commonly used as a probiotic due to its ability to promote digestive health and support immune function. It is a spore-forming, lactic acid-producing bacterium that can survive harsh conditions such as heat, acidity, and bile salts, making it highly resilient and effective as a dietary supplement. Bacillus coagulans aids in maintaining a healthy balance of gut flora by inhibiting the growth of harmful bacteria and promoting the growth of beneficial bacteria.

Market Dynamics:

Driver:

Expansion of the probiotics

Probiotics have gained considerable attention due to their potential health benefits, particularly in supporting digestive health and immune function. As a probiotic bacterium, Bacillus coagulans has benefited from this growing market trend. Furthermore, healthcare professionals and researchers have been actively promoting the benefits of probiotics, including Bacillus coagulans, through scientific studies and clinical trials. Positive findings from these studies have contributed to the credibility and acceptance of probiotics as a viable health solution, further propelling market expansion.

Restraint:

Product stability

Bacillus coagulans is a live bacterium that is sensitive to various environmental factors, including temperature, moisture, and oxygen exposure. However, Bacillus coagulans may have specific requirements for optimal growth and survival, including pH levels, nutrient availability, and compatibility with other ingredients. Maintaining the stability and viability of Bacillus coagulans throughout the product's shelf life can be challenging, and product instability can affect its effectiveness and consumer trust, which hampers the market demand.

Opportunity:

Increasing consumer awareness

As consumers become more conscious of their health and well-being, there is a growing demand for natural and effective solutions to support digestive health. Bacillus coagulans, with its properties, has gained attention as a potential remedy, leading to increased consumer awareness and demand. Furthermore, health and wellness publications, online resources, social media, and word-of-mouth recommendations have all played a role in educating consumers about the benefits of Bacillus coagulans.

Threat:

Competition from alternative products

Alternative probiotic strains, such as Lactobacillus and Bifidobacterium species, offer similar health benefits and are well-established in the market, creating a competitive landscape. Additionally, non-probiotic alternatives, such as prebiotics, synbiotics, and conventional pharmaceuticals, compete for market share by targeting similar health conditions or wellness goals. The presence of established competitors and alternative products underscores the importance of differentiation and value proposition for Bacillus coagulans products, which impact the market demand.

Covid-19 Impact

The global Bacillus Coagulans market has experienced significant impacts due to the COVID-19 pandemic. The pandemic has led to a revaluation of health priorities, resulting in an increased demand for functional foods and probiotics, including Bacillus Coagulans. Moreover, the pandemic has caused disruptions in the supply chain, impacting the commercial manufacturing of functional food products in various regions.

The powder segment is expected to be the largest during the forecast period

The powder segment is estimated to hold the largest share, due to their versatility, convenience, and ease of incorporation into various applications. Bacillus coagulans powder is a concentrated form of the probiotic bacterium, often used in dietary supplements, functional foods, and animal feed additives. Moreover, powdered Bacillus coagulans supplements offer consumers a convenient way to incorporate probiotics into their daily routines. The powder can be easily mixed into beverages, yogurt, or sprinkled over food, providing a simple and customizable way to boost gut health and immunity.

The non-dairy segment is expected to have the highest CAGR during the forecast period

The non-dairy segment is anticipated to have lucrative growth during the forecast period, due to the increasing demand for dairy-free and vegan-friendly probiotic products. Bacillus coagulans, being a resilient spore-forming bacterium, is well-suited for incorporation into non-dairy foods and beverages, offering consumers alternative options for obtaining the health benefits associated with probiotics. Moreover, the growing trend towards clean label and natural ingredients has further fuelled the demand for non-dairy probiotic options, as Bacillus coagulans is often perceived as a natural and clean-label-friendly ingredient.

Region with largest share:

North America commanded the largest market share during the extrapolated period. With increasing awareness among consumers about the importance of digestive health and wellness, there has been a growing demand for products containing Bacillus coagulans. This demand is driven by factors such as hectic lifestyles, poor dietary habits, and rising incidences of digestive disorders. Moreover, the regulatory environment in North America, particularly in the United States and Canada, supports the use of bacillus coagulans in food and dietary supplements, further driving its market growth.

Region with highest CAGR:

Asia Pacific is expected to witness profitable growth over the projection period, due to large and diverse population, increasing disposable income, and rising health consciousness. Bacillus coagulans, with its ability to withstand high temperatures and acidic environments, is well-suited for fermentation processes, making it a popular choice for enhancing the nutritional value and probiotic content of traditional Asian foods like kimchi, miso, tempeh, and pickles. Furthermore, the prevalence of gastrointestinal disorders and digestive health concerns in the region has heightened awareness of the importance of gut health and probiotics.

Key players in the market

Some of the key players in the Bacillus Coagulans Market include Mitsubishi Chemical Foods Corporation, Aumgene Bioscience, Nebraska Cultures, Syngen Biotech, Sabinsa Corporation, UAS Laboratories, Ganeden, Microbax, Mystical Biotech Pvt. Ltd, Sanzyme, Synbiotics Limited, Lallemand Inc., Bioriginal Food & Science Corp., Unique Biotech Limited and Biovation Labs Inc.

Key Developments:

In February 2024, Bioriginal Food & Science Corp. a wholly-owned subsidiary of Cooke Inc., has announced the acquisition of POS Biosciences Corp. (Saskatoon, Saskatchewan, Canada) from Canopy Growth Corp.

In October 2023, Bioriginal Food & Science Corp. has expanded into Germany with the acquisition of Pflanzenolmuhle Kroppenstedt GmbH operating as Kroppenstedter Olmuhle, a century-old, family-owned mill that specializes in the pressing of plant-based oil products from conventional and organic sources.

In August 2023, Synbiotics Limited acquired CannaCare Health GmbH with its strong CBD brand Canobo as well as the emerging CBD network marketing subsidiary WellnetIQ.

In April 2021, Mitsubishi Chemical Corporation has entered into a partnership agreement with Dymon Co., Ltd. the robot and space development venture, the first private company ever to explore the moon. Based on this agreement, MCC will provide carbon fiber reinforced plastic (CFRP) components and thermoplastic materials as well as technical support.

Product Types Covered:

  • Animal-Based
  • Plant-Based

Forms Covered:

  • Spore
  • Liquid
  • Powder

Distribution Channels Covered:

  • Offline Retail
  • Online Retail

Applications Covered:

  • Cereal
  • Infant Nutrition
  • Non-Dairy
  • Probiotic Supplements
  • Other Applications

End Users Covered:

  • Food & Beverages
  • Cosmetics
  • Nutraceuticals
  • Pharmaceutical
  • Animal Husbandry
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Bacillus Coagulans Market, By Product Type

  • 5.1 Introduction
  • 5.2 Animal-Based
  • 5.3 Plant-Based

6 Global Bacillus Coagulans Market, By Form

  • 6.1 Introduction
  • 6.2 Spore
  • 6.3 Liquid
  • 6.4 Powder

7 Global Bacillus Coagulans Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Offline Retail
  • 7.3 Online Retail

8 Global Bacillus Coagulans Market, By Application

  • 8.1 Introduction
  • 8.2 Cereal
  • 8.3 Infant Nutrition
  • 8.4 Non-Dairy
  • 8.5 Probiotic Supplements
  • 8.6 Other Applications

9 Global Bacillus Coagulans Market, By End User

  • 9.1 Introduction
  • 9.2 Food & Beverages
  • 9.3 Cosmetics
  • 9.4 Nutraceuticals
  • 9.5 Pharmaceutical
  • 9.6 Animal Husbandry
  • 9.7 Other End Users

10 Global Bacillus Coagulans Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Mitsubishi Chemical Foods Corporation
  • 12.2 Aumgene Bioscience
  • 12.3 Nebraska Cultures
  • 12.4 Syngen Biotech
  • 12.5 Sabinsa Corporation
  • 12.6 UAS Laboratories
  • 12.7 Ganeden
  • 12.8 Microbax
  • 12.9 Mystical Biotech Pvt. Ltd
  • 12.10 Sanzyme
  • 12.11 Synbiotics Limited
  • 12.12 Lallemand Inc.
  • 12.13 Bioriginal Food & Science Corp.
  • 12.14 Unique Biotech Limited
  • 12.15 Biovation Labs Inc.

List of Tables

  • Table 1 Global Bacillus Coagulans Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Bacillus Coagulans Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 3 Global Bacillus Coagulans Market Outlook, By Animal-Based (2021-2030) ($MN)
  • Table 4 Global Bacillus Coagulans Market Outlook, By Plant-Based (2021-2030) ($MN)
  • Table 5 Global Bacillus Coagulans Market Outlook, By Form (2021-2030) ($MN)
  • Table 6 Global Bacillus Coagulans Market Outlook, By Spore (2021-2030) ($MN)
  • Table 7 Global Bacillus Coagulans Market Outlook, By Liquid (2021-2030) ($MN)
  • Table 8 Global Bacillus Coagulans Market Outlook, By Powder (2021-2030) ($MN)
  • Table 9 Global Bacillus Coagulans Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 10 Global Bacillus Coagulans Market Outlook, By Offline Retail (2021-2030) ($MN)
  • Table 11 Global Bacillus Coagulans Market Outlook, By Online Retail (2021-2030) ($MN)
  • Table 12 Global Bacillus Coagulans Market Outlook, By Application (2021-2030) ($MN)
  • Table 13 Global Bacillus Coagulans Market Outlook, By Cereal (2021-2030) ($MN)
  • Table 14 Global Bacillus Coagulans Market Outlook, By Infant Nutrition (2021-2030) ($MN)
  • Table 15 Global Bacillus Coagulans Market Outlook, By Non-Dairy (2021-2030) ($MN)
  • Table 16 Global Bacillus Coagulans Market Outlook, By Probiotic Supplements (2021-2030) ($MN)
  • Table 17 Global Bacillus Coagulans Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 18 Global Bacillus Coagulans Market Outlook, By End User (2021-2030) ($MN)
  • Table 19 Global Bacillus Coagulans Market Outlook, By Food & Beverages (2021-2030) ($MN)
  • Table 20 Global Bacillus Coagulans Market Outlook, By Cosmetics (2021-2030) ($MN)
  • Table 21 Global Bacillus Coagulans Market Outlook, By Nutraceuticals (2021-2030) ($MN)
  • Table 22 Global Bacillus Coagulans Market Outlook, By Pharmaceutical (2021-2030) ($MN)
  • Table 23 Global Bacillus Coagulans Market Outlook, By Animal Husbandry (2021-2030) ($MN)
  • Table 24 Global Bacillus Coagulans Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 25 North America Bacillus Coagulans Market Outlook, By Country (2021-2030) ($MN)
  • Table 26 North America Bacillus Coagulans Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 27 North America Bacillus Coagulans Market Outlook, By Animal-Based (2021-2030) ($MN)
  • Table 28 North America Bacillus Coagulans Market Outlook, By Plant-Based (2021-2030) ($MN)
  • Table 29 North America Bacillus Coagulans Market Outlook, By Form (2021-2030) ($MN)
  • Table 30 North America Bacillus Coagulans Market Outlook, By Spore (2021-2030) ($MN)
  • Table 31 North America Bacillus Coagulans Market Outlook, By Liquid (2021-2030) ($MN)
  • Table 32 North America Bacillus Coagulans Market Outlook, By Powder (2021-2030) ($MN)
  • Table 33 North America Bacillus Coagulans Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 34 North America Bacillus Coagulans Market Outlook, By Offline Retail (2021-2030) ($MN)
  • Table 35 North America Bacillus Coagulans Market Outlook, By Online Retail (2021-2030) ($MN)
  • Table 36 North America Bacillus Coagulans Market Outlook, By Application (2021-2030) ($MN)
  • Table 37 North America Bacillus Coagulans Market Outlook, By Cereal (2021-2030) ($MN)
  • Table 38 North America Bacillus Coagulans Market Outlook, By Infant Nutrition (2021-2030) ($MN)
  • Table 39 North America Bacillus Coagulans Market Outlook, By Non-Dairy (2021-2030) ($MN)
  • Table 40 North America Bacillus Coagulans Market Outlook, By Probiotic Supplements (2021-2030) ($MN)
  • Table 41 North America Bacillus Coagulans Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 42 North America Bacillus Coagulans Market Outlook, By End User (2021-2030) ($MN)
  • Table 43 North America Bacillus Coagulans Market Outlook, By Food & Beverages (2021-2030) ($MN)
  • Table 44 North America Bacillus Coagulans Market Outlook, By Cosmetics (2021-2030) ($MN)
  • Table 45 North America Bacillus Coagulans Market Outlook, By Nutraceuticals (2021-2030) ($MN)
  • Table 46 North America Bacillus Coagulans Market Outlook, By Pharmaceutical (2021-2030) ($MN)
  • Table 47 North America Bacillus Coagulans Market Outlook, By Animal Husbandry (2021-2030) ($MN)
  • Table 48 North America Bacillus Coagulans Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 49 Europe Bacillus Coagulans Market Outlook, By Country (2021-2030) ($MN)
  • Table 50 Europe Bacillus Coagulans Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 51 Europe Bacillus Coagulans Market Outlook, By Animal-Based (2021-2030) ($MN)
  • Table 52 Europe Bacillus Coagulans Market Outlook, By Plant-Based (2021-2030) ($MN)
  • Table 53 Europe Bacillus Coagulans Market Outlook, By Form (2021-2030) ($MN)
  • Table 54 Europe Bacillus Coagulans Market Outlook, By Spore (2021-2030) ($MN)
  • Table 55 Europe Bacillus Coagulans Market Outlook, By Liquid (2021-2030) ($MN)
  • Table 56 Europe Bacillus Coagulans Market Outlook, By Powder (2021-2030) ($MN)
  • Table 57 Europe Bacillus Coagulans Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 58 Europe Bacillus Coagulans Market Outlook, By Offline Retail (2021-2030) ($MN)
  • Table 59 Europe Bacillus Coagulans Market Outlook, By Online Retail (2021-2030) ($MN)
  • Table 60 Europe Bacillus Coagulans Market Outlook, By Application (2021-2030) ($MN)
  • Table 61 Europe Bacillus Coagulans Market Outlook, By Cereal (2021-2030) ($MN)
  • Table 62 Europe Bacillus Coagulans Market Outlook, By Infant Nutrition (2021-2030) ($MN)
  • Table 63 Europe Bacillus Coagulans Market Outlook, By Non-Dairy (2021-2030) ($MN)
  • Table 64 Europe Bacillus Coagulans Market Outlook, By Probiotic Supplements (2021-2030) ($MN)
  • Table 65 Europe Bacillus Coagulans Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 66 Europe Bacillus Coagulans Market Outlook, By End User (2021-2030) ($MN)
  • Table 67 Europe Bacillus Coagulans Market Outlook, By Food & Beverages (2021-2030) ($MN)
  • Table 68 Europe Bacillus Coagulans Market Outlook, By Cosmetics (2021-2030) ($MN)
  • Table 69 Europe Bacillus Coagulans Market Outlook, By Nutraceuticals (2021-2030) ($MN)
  • Table 70 Europe Bacillus Coagulans Market Outlook, By Pharmaceutical (2021-2030) ($MN)
  • Table 71 Europe Bacillus Coagulans Market Outlook, By Animal Husbandry (2021-2030) ($MN)
  • Table 72 Europe Bacillus Coagulans Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 73 Asia Pacific Bacillus Coagulans Market Outlook, By Country (2021-2030) ($MN)
  • Table 74 Asia Pacific Bacillus Coagulans Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 75 Asia Pacific Bacillus Coagulans Market Outlook, By Animal-Based (2021-2030) ($MN)
  • Table 76 Asia Pacific Bacillus Coagulans Market Outlook, By Plant-Based (2021-2030) ($MN)
  • Table 77 Asia Pacific Bacillus Coagulans Market Outlook, By Form (2021-2030) ($MN)
  • Table 78 Asia Pacific Bacillus Coagulans Market Outlook, By Spore (2021-2030) ($MN)
  • Table 79 Asia Pacific Bacillus Coagulans Market Outlook, By Liquid (2021-2030) ($MN)
  • Table 80 Asia Pacific Bacillus Coagulans Market Outlook, By Powder (2021-2030) ($MN)
  • Table 81 Asia Pacific Bacillus Coagulans Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 82 Asia Pacific Bacillus Coagulans Market Outlook, By Offline Retail (2021-2030) ($MN)
  • Table 83 Asia Pacific Bacillus Coagulans Market Outlook, By Online Retail (2021-2030) ($MN)
  • Table 84 Asia Pacific Bacillus Coagulans Market Outlook, By Application (2021-2030) ($MN)
  • Table 85 Asia Pacific Bacillus Coagulans Market Outlook, By Cereal (2021-2030) ($MN)
  • Table 86 Asia Pacific Bacillus Coagulans Market Outlook, By Infant Nutrition (2021-2030) ($MN)
  • Table 87 Asia Pacific Bacillus Coagulans Market Outlook, By Non-Dairy (2021-2030) ($MN)
  • Table 88 Asia Pacific Bacillus Coagulans Market Outlook, By Probiotic Supplements (2021-2030) ($MN)
  • Table 89 Asia Pacific Bacillus Coagulans Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 90 Asia Pacific Bacillus Coagulans Market Outlook, By End User (2021-2030) ($MN)
  • Table 91 Asia Pacific Bacillus Coagulans Market Outlook, By Food & Beverages (2021-2030) ($MN)
  • Table 92 Asia Pacific Bacillus Coagulans Market Outlook, By Cosmetics (2021-2030) ($MN)
  • Table 93 Asia Pacific Bacillus Coagulans Market Outlook, By Nutraceuticals (2021-2030) ($MN)
  • Table 94 Asia Pacific Bacillus Coagulans Market Outlook, By Pharmaceutical (2021-2030) ($MN)
  • Table 95 Asia Pacific Bacillus Coagulans Market Outlook, By Animal Husbandry (2021-2030) ($MN)
  • Table 96 Asia Pacific Bacillus Coagulans Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 97 South America Bacillus Coagulans Market Outlook, By Country (2021-2030) ($MN)
  • Table 98 South America Bacillus Coagulans Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 99 South America Bacillus Coagulans Market Outlook, By Animal-Based (2021-2030) ($MN)
  • Table 100 South America Bacillus Coagulans Market Outlook, By Plant-Based (2021-2030) ($MN)
  • Table 101 South America Bacillus Coagulans Market Outlook, By Form (2021-2030) ($MN)
  • Table 102 South America Bacillus Coagulans Market Outlook, By Spore (2021-2030) ($MN)
  • Table 103 South America Bacillus Coagulans Market Outlook, By Liquid (2021-2030) ($MN)
  • Table 104 South America Bacillus Coagulans Market Outlook, By Powder (2021-2030) ($MN)
  • Table 105 South America Bacillus Coagulans Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 106 South America Bacillus Coagulans Market Outlook, By Offline Retail (2021-2030) ($MN)
  • Table 107 South America Bacillus Coagulans Market Outlook, By Online Retail (2021-2030) ($MN)
  • Table 108 South America Bacillus Coagulans Market Outlook, By Application (2021-2030) ($MN)
  • Table 109 South America Bacillus Coagulans Market Outlook, By Cereal (2021-2030) ($MN)
  • Table 110 South America Bacillus Coagulans Market Outlook, By Infant Nutrition (2021-2030) ($MN)
  • Table 111 South America Bacillus Coagulans Market Outlook, By Non-Dairy (2021-2030) ($MN)
  • Table 112 South America Bacillus Coagulans Market Outlook, By Probiotic Supplements (2021-2030) ($MN)
  • Table 113 South America Bacillus Coagulans Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 114 South America Bacillus Coagulans Market Outlook, By End User (2021-2030) ($MN)
  • Table 115 South America Bacillus Coagulans Market Outlook, By Food & Beverages (2021-2030) ($MN)
  • Table 116 South America Bacillus Coagulans Market Outlook, By Cosmetics (2021-2030) ($MN)
  • Table 117 South America Bacillus Coagulans Market Outlook, By Nutraceuticals (2021-2030) ($MN)
  • Table 118 South America Bacillus Coagulans Market Outlook, By Pharmaceutical (2021-2030) ($MN)
  • Table 119 South America Bacillus Coagulans Market Outlook, By Animal Husbandry (2021-2030) ($MN)
  • Table 120 South America Bacillus Coagulans Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 121 Middle East & Africa Bacillus Coagulans Market Outlook, By Country (2021-2030) ($MN)
  • Table 122 Middle East & Africa Bacillus Coagulans Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 123 Middle East & Africa Bacillus Coagulans Market Outlook, By Animal-Based (2021-2030) ($MN)
  • Table 124 Middle East & Africa Bacillus Coagulans Market Outlook, By Plant-Based (2021-2030) ($MN)
  • Table 125 Middle East & Africa Bacillus Coagulans Market Outlook, By Form (2021-2030) ($MN)
  • Table 126 Middle East & Africa Bacillus Coagulans Market Outlook, By Spore (2021-2030) ($MN)
  • Table 127 Middle East & Africa Bacillus Coagulans Market Outlook, By Liquid (2021-2030) ($MN)
  • Table 128 Middle East & Africa Bacillus Coagulans Market Outlook, By Powder (2021-2030) ($MN)
  • Table 129 Middle East & Africa Bacillus Coagulans Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 130 Middle East & Africa Bacillus Coagulans Market Outlook, By Offline Retail (2021-2030) ($MN)
  • Table 131 Middle East & Africa Bacillus Coagulans Market Outlook, By Online Retail (2021-2030) ($MN)
  • Table 132 Middle East & Africa Bacillus Coagulans Market Outlook, By Application (2021-2030) ($MN)
  • Table 133 Middle East & Africa Bacillus Coagulans Market Outlook, By Cereal (2021-2030) ($MN)
  • Table 134 Middle East & Africa Bacillus Coagulans Market Outlook, By Infant Nutrition (2021-2030) ($MN)
  • Table 135 Middle East & Africa Bacillus Coagulans Market Outlook, By Non-Dairy (2021-2030) ($MN)
  • Table 136 Middle East & Africa Bacillus Coagulans Market Outlook, By Probiotic Supplements (2021-2030) ($MN)
  • Table 137 Middle East & Africa Bacillus Coagulans Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 138 Middle East & Africa Bacillus Coagulans Market Outlook, By End User (2021-2030) ($MN)
  • Table 139 Middle East & Africa Bacillus Coagulans Market Outlook, By Food & Beverages (2021-2030) ($MN)
  • Table 140 Middle East & Africa Bacillus Coagulans Market Outlook, By Cosmetics (2021-2030) ($MN)
  • Table 141 Middle East & Africa Bacillus Coagulans Market Outlook, By Nutraceuticals (2021-2030) ($MN)
  • Table 142 Middle East & Africa Bacillus Coagulans Market Outlook, By Pharmaceutical (2021-2030) ($MN)
  • Table 143 Middle East & Africa Bacillus Coagulans Market Outlook, By Animal Husbandry (2021-2030) ($MN)
  • Table 144 Middle East & Africa Bacillus Coagulans Market Outlook, By Other End Users (2021-2030) ($MN)